{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:32:32Z","timestamp":1789997552457,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004083","name":"Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["2015M3A9B6029138"],"award-info":[{"award-number":["2015M3A9B6029138"]}],"id":[{"id":"10.13039\/501100004083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.atherosclerosis.2019.02.026","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T01:52:56Z","timestamp":1551664376000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Statin and clinical outcomes of primary prevention in individuals aged >75\u202fyears: The SCOPE-75 study"],"prefix":"10.1016","volume":"284","author":[{"given":"Kyu","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Young","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2263-3274","authenticated-orcid":false,"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5362-478X","authenticated-orcid":false,"given":"Sungha","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk-Jae","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geu-Ru","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7748-5788","authenticated-orcid":false,"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Won","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-3112","authenticated-orcid":false,"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9602","key":"10.1016\/j.atherosclerosis.2019.02.026_bib1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2019.02.026_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005025","article-title":"A coronary heart disease prediction model: the Korean Heart Study","volume":"4","author":"Jee","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.02.026_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-147-1-200707030-00002","article-title":"Treating to New Targets Study Steering Committee and Investigators. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease","volume":"147","author":"Wenger","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.02.026_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2007.06.063","article-title":"Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis","volume":"51","author":"Afilalo","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2019.02.026_bib5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.2014.10924","article-title":"Evaluation and treatment of older patients with hypercholesterolemia: a clinical review","volume":"312","author":"Strandberg","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2019.02.026_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-152-8-201004200-00005","article-title":"Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial","volume":"152","author":"Glynn","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2019.02.026_bib7","doi-asserted-by":"crossref","first-page":"e4535","DOI":"10.1136\/bmj.e4535","article-title":"Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study","volume":"345","author":"Sheppard","year":"2012","journal-title":"BMJ"},{"issue":"25 Suppl 2","key":"10.1016\/j.atherosclerosis.2019.02.026_bib8","first-page":"S1","article-title":"ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"129","author":"Stone","year":"2013","journal-title":"Circulation"},{"issue":"29","key":"10.1016\/j.atherosclerosis.2019.02.026_bib9","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"issue":"39","key":"10.1016\/j.atherosclerosis.2019.02.026_bib10","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.02.026_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002333","article-title":"Statin use and clinical outcomes in older men: a prospective population-based study","volume":"3","author":"Gnjidic","year":"2013","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.02.026_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7326\/L15-5135-3","article-title":"Statins for primary prevention in adults aged 75 years or older","volume":"163","author":"Odden","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2019.02.026_bib13","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9542","key":"10.1016\/j.atherosclerosis.2019.02.026_bib14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2019.02.026_bib15","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2019.02.026_bib16","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.jacc.2013.07.069","article-title":"Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis","volume":"62","author":"Savarese","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9346","key":"10.1016\/j.atherosclerosis.2019.02.026_bib17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"issue":"9753","key":"10.1016\/j.atherosclerosis.2019.02.026_bib18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2019.02.026_bib19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamainternmed.2017.1442","article-title":"Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial","volume":"177","author":"Han","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.02.026_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/ageing\/afq129","article-title":"Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds","volume":"39","author":"Petersen","year":"2010","journal-title":"Age Ageing"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2019.02.026_bib21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jamda.2013.08.012","article-title":"Cholesterol, statins, and longevity from age 70 to 90 years","volume":"14","author":"Jacobs","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.atherosclerosis.2019.02.026_bib22","doi-asserted-by":"crossref","first-page":"k3359","DOI":"10.1136\/bmj.k3359","article-title":"Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study","volume":"362","author":"Ramos","year":"2018","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2019.02.026_bib23","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2012.06.058","article-title":"Appropriateness of statins in patients aged \u226580 years and comparison to other age groups","volume":"110","author":"Chokshi","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.02.026_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the national cholesterol education Program adult treatment panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.02.026_bib25","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of Cardiology (ESC) and the European atherosclerosis society (EAS)","volume":"32","author":"European Association for Cardiovascular Prevention & Rehabilitation","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.02.026_bib26","first-page":"S1","article-title":"ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.02.026_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2019.02.026_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s40266-015-0290-9","article-title":"Statins for primary prevention of cardiovascular disease in elderly patients: systematic review and meta-analysis","volume":"32","author":"Teng","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.atherosclerosis.2019.02.026_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1741-7015-3-6","article-title":"The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]","volume":"3","author":"Heart Protection Study Collaborative Group","year":"2005","journal-title":"BMC Med."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2019.02.026_bib30","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehr333","article-title":"The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K","volume":"32","author":"Sever","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.02.026_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2018.12.032","article-title":"Real-life of statins for cardiovascular prevention in elderly subjects: a population-based cohort study","author":"Bezin","year":"2019","journal-title":"Am. J. Med."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2019.02.026_bib32","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.02.026_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5551\/jat.RV16004","article-title":"Racial differences in the cholesterol-lowering effect of statin","volume":"24","author":"Naito","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.02.026_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000132","article-title":"Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study","volume":"1","author":"Olafsdottir","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.atherosclerosis.2019.02.026_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jff.2013.12.006","article-title":"Mutraceuticals and dyslipidaemia: beyond the common therapeutics","volume":"6","author":"Scicchitano","year":"2014","journal-title":"J Funct Foods"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019301133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019301133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:37:59Z","timestamp":1758155879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019301133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":35,"alternative-id":["S0021915019301133"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.026","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin and clinical outcomes of primary prevention in individuals aged >75\u202fyears: The SCOPE-75 study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}